PT  - JOURNAL ARTICLE
AU  - Fischer, Robert J.
AU  - Morris, Dylan H.
AU  - van Doremalen, Neeltje
AU  - Sarchette, Shanda
AU  - Matson, M. Jeremiah
AU  - Bushmaker, Trenton
AU  - Yinda, Claude Kwe
AU  - Seifert, Stephanie N.
AU  - Gamble, Amandine
AU  - Williamson, Brandi N.
AU  - Judson, Seth D.
AU  - de Wit, Emmie
AU  - Lloyd-Smith, James O.
AU  - Munster, Vincent J.
TI  - Assessment of N95 respirator decontamination and re-use for SARS-CoV-2
AID  - 10.1101/2020.04.11.20062018
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.11.20062018
4099  - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20062018.short
4100  - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20062018.full
AB  - The unprecedented pandemic of COVID-19 has created worldwide shortages of personal protective equipment, in particular respiratory protection such as N95 respirators1. SARS-CoV-2 transmission is frequently occurring in hospital settings, with numerous reported cases of nosocomial transmission highlighting the vulnerability of healthcare workers2–4. In general, N95 respirators are designed for single use prior to disposal. Several groups have addressed the potential for re-use of N95 respirators from a mechanical or from a decontamination perspective (for a full literature overview see Supplementary Appendix).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). JOL-S and AG were supported by the Defense Advanced Research Projects Agency DARPA PREEMPT # D18AC00031 and the UCLA AIDS Institute and Charity Treks, and JOL-S was supported by the U.S. National Science Foundation (DEB-1557022), the Strategic Environmental Research and Development Program (SERDP, RC-2635) of the U.S. Department of Defense. no payment was received from third parties.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data to reproduce the Bayesian estimation results and produce corresponding figures are archived online at OSF: and available on Github: